dc.contributor.author
Nadal Rodríguez, Pau
dc.contributor.author
Hartung, Frederick
dc.contributor.author
Pedrola Teixell, Marina
dc.contributor.author
Coomar, Seemon
dc.contributor.author
Diaz-Moreno, Alejandro
dc.contributor.author
Hätälä, Anna M.
dc.contributor.author
Rolfes, Katharina M.
dc.contributor.author
Sánchez-Vera, Ismael
dc.contributor.author
Gil, Joan
dc.contributor.author
Molins i Grau, Elies
dc.contributor.author
Viayna Gaza, Antonio
dc.contributor.author
Hanzl, Alexander
dc.contributor.author
Thomä, Nicolas H.
dc.contributor.author
Haarmann-Stemmann, Thomas
dc.contributor.author
Luque Garriga, F. Xavier
dc.contributor.author
Lavilla Grífols, Rodolfo
dc.contributor.author
Ghashghaei, Ouldouz
dc.date.issued
2025-06-23T06:58:29Z
dc.date.issued
2025-06-23T06:58:29Z
dc.date.issued
2025-04-10
dc.date.issued
2025-06-23T06:58:29Z
dc.identifier
https://hdl.handle.net/2445/221704
dc.description.abstract
A multidisciplinary platform is presented to address aryl hydrocarbon receptor (AhR) modulation. A rewired Yonemitsu multicomponent reaction with indole 2-carboxaldehydes and nucleophilic species was designed to access a family of 6-substituted indolocarbazoles. The conformational behavior of these compounds was examined to rationalize their axial chirality. In silico docking and molecular simulations highlighted key features implicated in their binding to AhR. Furthermore, the synthesis of linkable derivatives allowed the direct development of conjugated entities. Reporter gene and target gene expression analyses identified these novel structures as potent noncytotoxic activating AhR ligands, that can be extended to bifunctional molecules. The anti-inflammatory properties of these AhR agonists were assessed in interleukin-13 treated keratinocytes. Altogether, the synergistic research in synthetic and computational chemistry integrated with biological studies opens novel avenues toward understanding the biological roles of AhR and the development of targeted therapeutics.
dc.format
application/pdf
dc.publisher
American Chemical Society
dc.relation
Reproducció del document publicat a: https://doi.org/10.1021/acscentsci.5c00194
dc.relation
ACS Central Science, 2025, num.11
dc.relation
https://doi.org/10.1021/acscentsci.5c00194
dc.rights
cc by (c) Pau Nadal Rodríguez, et al., 2025
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Química farmacèutica
dc.subject
Síntesi orgànica
dc.subject
Compostos heterocíclics
dc.subject
Pharmaceutical chemistry
dc.subject
Organic synthesis
dc.subject
Heterocyclic compounds
dc.title
A multicomponent reaction-based platform opens new avenues in Aryl Hydrocarbon Receptor modulation
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion